Reply to: Response to “Inconsistent platelet-rich plasma product from Food and Drug Administration cleared devices: A retrospective review of clinic data” - 07/08/21

Ronda S. Farah, MD ^{a, ⁎} , Noora Hussain, BS ^b, Javed A. Shaik, PhD ^a, Neil Sadick, MD ^{a, c, d}, Graham Gregorich, BS ^e, Jessica Asiala, BS ^e, Rebecca Freese, MS ^f, Maria Hordinsky, MD ^a

^a Department of Dermatology, University of Minnesota, Minneapolis, Minnesota 

^b College of Continuing and Professional Studies, University of Minnesota, Minneapolis, Minnesota 

^c Sadick Dermatology, New York, New York 

^d Weill Cornell Medical College, New York, New York 

^e Blood Bank Quality Center, University of Minnesota Medical Center, Minneapolis, Minnesota 

^f Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota 

^∗Correspondence to: Ronda S. Farah, MD, University of Minnesota, Department of Dermatology, 516 Delaware St. SE MMC 98, Minneapolis, MN 55455University of MinnesotaDepartment of Dermatology516 Delaware St. SE MMC 98MinneapolisMN55455

Le texte complet de cet article est disponible en PDF.